RxSight (RXST) Change in Acquisitions & Divestments (2020 - 2026)

RxSight (RXST) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $110.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 83.33% year-over-year to $110.0 million; the trailing twelve-month figure through Mar 2026 stood at $310.0 million (up 35.37% YoY), and the FY2025 full-year result was $260.0 million, up 7.0% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $110.0 million, up from $90.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $110.0 million in Q1 2026 and bottomed at $45.0 million in Q2 2022.
• The 5-year median for Change in Acquisitions & Divestments is $60.0 million (2023), against an average of $66.1 million.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments soared 400.0%; it then tumbled 33.33% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $45.0 million in 2022, then gained by 11.11% to $50.0 million in 2023, then grew by 10.0% to $55.0 million in 2024, then surged by 63.64% to $90.0 million in 2025, then grew by 22.22% to $110.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $110.0 million (Q1 2026), $90.0 million (Q4 2025), and $60.0 million (Q3 2025), per Business Quant data.

Peer Comparison